Treatment of metastatic carcinoid tumours, phaeochromocytoma, paraganglioma and medullary carcinoma of the thyroid with (131)I-meta-iodobenzylguanidine [(131)I-mIBG].

Treatment of metastatic carcinoid tumours, phaeochromocytoma, paraganglioma and medullary carcinoma of the thyroid with (131)I-meta-iodobenzylguanidine [(131)I-mIBG].

OBJECTIVE: Meta-iodo-benzyl-guanidine labelled with 131-iodine [(131)I-mIBG] has been used extensively for imaging tumours originating from the neural crest but experience with its therapeutic use is limited, particularly for non-catecholamine secreting tumours. In order to assess the therapeutic re...

Bibliografiset tiedot
Päätekijät:	Mukherjee, J, Kaltsas, G, Islam, N, Plowman, P, Foley, R, Hikmat, J, Britton, K, Jenkins, P, Chew, S, Monson, J, Besser, G, Grossman, AB
Aineistotyyppi:	Journal article
Kieli:	English
Julkaistu:	2001

Samankaltaisia teoksia

Treatment of metastatic pheochromocytoma and paraganglioma with I-131-meta-iodobenzylguanidine (MIBG)
Tekijä: Kaltsas, G, et al.
Julkaistu: (2003)

Treatment of malignant phaeochromocytoma, paraganglioma and carcinoid tumours with 131I-metaiodobenzylguanidine.
Tekijä: Bomanji, J, et al.
Julkaistu: (1993)

Peptide Receptor Radionuclide Treatment and (131)I-MIBG in the management of patients with metastatic/progressive phaeochromocytomas and paragangliomas
Tekijä: Nastos, K, et al.
Julkaistu: (2017)

Sequelae and survivorship in patients treated with (131)I-MIBG therapy.
Tekijä: Sze, W, et al.
Julkaistu: (2013)

Sequelae and survivorship in patients treated with 131 I-MIBG therapy
Tekijä: Sze, W, et al.
Julkaistu: (2013)

Ocular metastases secondary to carcinoid tumors: the utility of imaging with [(123)I]meta-iodobenzylguanidine and [(111)In]DTPA pentetreotide.
Tekijä: Isidori, A, et al.
Julkaistu: (2002)

Improved outcome of 131I-mIBG treatment through combination with external beam radiotherapy in the SK-N-SH mouse model of neuroblastoma
Tekijä: Corroyer-Dulmont, A, et al.
Julkaistu: (2017)

I-123 imaging for the prediction of I-131 therapy for recurrent differentiated thyroid cancer, RDTC, when I-131 tracer is negative but raised thyroglobulin, Tg
Tekijä: Britton, K, et al.
Julkaistu: (1999)

The diagnosis and management of malignant phaeochromocytoma and paraganglioma.
Tekijä: Chrisoulidou, A, et al.
Julkaistu: (2007)

Carcinoid tumours presenting as breast cancer: the utility of radionuclide imaging with 123I-MIBG and 111In-DTPA pentetreotide.
Tekijä: Kaltsas, G, et al.
Julkaistu: (1998)

Routine preoperative (123)I-MIBG scintigraphy for patients with phaeochromocytoma is not necessary.
Tekijä: Mihai, R, et al.
Julkaistu: (2008)

The management of differentiated thyroid cancer using 123I for imaging to assess the need for 131I therapy.
Tekijä: Ali, N, et al.
Julkaistu: (2006)

I131-MIBG treatment revisited: How important is scheduling when combined with external beam irradiation?
Tekijä: Corroyer-Dulmont, A, et al.
Julkaistu: (2016)

123I-metaiodobenzylguanidine (MIBG) scintigraphy for the detection of adrenal and extra-adrenal phaeochromocytomas: CT and MRI correlation.
Tekijä: Bhatia, K, et al.
Julkaistu: (2008)

MIBG scans for phaeochromocytoma: time to abandon the technique?
Tekijä: Grossman, A, et al.
Julkaistu: (2009)

The role of 123I-diagnostic imaging in the follow-up of patients with differentiated thyroid carcinoma as compared to 131I-scanning: avoidance of negative therapeutic uptake due to stunning.
Tekijä: Siddiqi, A, et al.
Julkaistu: (2001)

Naloxone provokes catecholamine release in phaeochromocytomas and paragangliomas.
Tekijä: Bouloux, P, et al.
Julkaistu: (1986)

The clinical presentation (symptoms and signs) of sporadic and familial chromaffin cell tumours (phaeochromocytomas and paragangliomas).
Tekijä: Kaltsas, G, et al.
Julkaistu: (2004)

Dopamine-secreting phaeochromocytomas and paragangliomas: clinical features and management
Tekijä: Foo, S.H., et al.
Julkaistu: (2010)

NMR-ON MEASUREMENTS OF I-123, I-124, I-131 IN NICKEL
Tekijä: Ohya, S, et al.
Julkaistu: (1992)

Clinical manifestations of familial paraganglioma and phaeochromocytomas in succinate dehydrogenase B (SDH-B) gene mutation carriers.
Tekijä: Srirangalingam, U, et al.
Julkaistu: (2008)

KFT 131 ï¿½ KIMIA FIZIK I APR 01.
Tekijä: PPSK, Pusat Pengajian Sains Kimia
Julkaistu: (2001)

KFT 131 ï¿½ KIMIA FIZIK I FEB 01.
Tekijä: PPSK, Pusat Pengajian Sains Kimia
Julkaistu: (2001)

Familial paraganglioma: a novel presentation of a case and response to therapy with radiolabelled MIBG.
Tekijä: Lawrence, J, et al.
Julkaistu: (2004)

Multimodality palliative treatment of (111)In-pentetreotide negative/(123)I-MIBG positive metastatic carcinoid - a case report.
Tekijä: Dworakowska, D, et al.
Julkaistu: (2008)

KFT 131 - PHYSICAL CHEMISTRY I APRIL 08.
Tekijä: PPSK, Pusat Pengajian Sains Kimia
Julkaistu: (2008)

KFT 131 - PHYSICAL CHEMISTRY I JUNE 08.
Tekijä: PPSK, Pusat Pengajian Sains Kimia
Julkaistu: (2008)

KFT 131 - KIMIA FIZIK I APRIL 04.
Tekijä: PPSK, Pusat Pengajian Sains Kimia
Julkaistu: (2004)

KFT 131 - KIMIA FIZIK I MAC 05.
Tekijä: PPSK, Pusat Pengajian Sains Kimia
Julkaistu: (2005)

KFT 131 - KIMIA FIZIK I APRIL 02.
Tekijä: PPSK, Pusat Pengajian Sains Kimia
Julkaistu: (2002)

KFT 131 - KIMIA FIZIK I APRIL 03.
Tekijä: PPSK, Pusat Pengajian Sains Kimia
Julkaistu: (2003)

KFT 131 - PHYSICAL CHEMISTRY I APRIL 07.
Tekijä: PPSK, Pusat Pengajian Sains Kimia
Julkaistu: (2007)

KFT 131 - PHYSICAL CHEMISTRY I JUNE 07.
Tekijä: PPSK, Pusat Pengajian Sains Kimia
Julkaistu: (2007)

KFT 131 - KIMIA FIZIK I APRIL 2000
Tekijä: PPSK, Pusat Pengajian Sains Kimia
Julkaistu: (2000)

KFT 131 - KIMIA FIZIK I APRIL 1999
Tekijä: PPSK, Pusat Pengajian Sains Kimia
Julkaistu: (1999)

KFT 131 - KIMIA FIZIK I FEB 98.
Tekijä: PPSK, Pusat Pengajian Sains Kimia
Julkaistu: (1998)

KFT 131 - KIMIA FIZIK I APRIL 98.
Tekijä: PPSK, Pusat Pengajian Sains Kimia
Julkaistu: (1998)

KFT 131 - KIMIA FIZIK I APRIL 1997.
Tekijä: PPSK, Pusat Pengajian Sains Kimia
Julkaistu: (1997)

NUCLEAR MAGNETIC-RESONANCE OF I-131 AND I-132 ORIENTED IN FE
Tekijä: James, P, et al.
Julkaistu: (1974)

Comparison of somatostatin analog and meta-iodobenzylguanidine radionuclides in the diagnosis and localization of advanced neuroendocrine tumors.
Tekijä: Kaltsas, G, et al.
Julkaistu: (2001)